dor_id: 4119816

506.#.#.a: Público

590.#.#.d: Los artículos enviados a la Revista Veterinaria México OA se juzgan por medio de un proceso de revisión por pares

510.0.#.a: Consejo Nacional de Ciencia y Tecnología (CONACyT), Sistema Regional de Información en Línea para Revistas Científicas de América Latina, el Caribe, España y Portugal (Latindex), Scientific Electronic Library Online (SciELO), Bibliografía Latinoamericana (Biblat), La Red de Revistas Científicas de América Latina y el Caribe, España y Portugal (Redalyc), Connecting research and researchers (ORCiD)

561.#.#.u: http://www.fmvz.unam.mx/

650.#.4.x: Biotecnología y Ciencias Agropecuarias

336.#.#.b: article

336.#.#.3: Artículo de Investigación

336.#.#.a: Artículo

351.#.#.6: http://veterinariamexico.unam.mx/index.php/vet/index

351.#.#.b: Veterinaria México OA

351.#.#.a: Artículos

harvesting_group: RevistasUNAM

270.1.#.p: Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx

590.#.#.c: Open Journal Systems (OJS)

270.#.#.d: MX

270.1.#.d: México

590.#.#.b: Concentrador

883.#.#.u: http://www.revistas.unam.mx/front/

883.#.#.a: Revistas UNAM

590.#.#.a: Coordinación de Difusión Cultural, UNAM

883.#.#.1: https://www.publicaciones.unam.mx/

883.#.#.q: Dirección General de Publicaciones y Fomento Editorial, UNAM

850.#.#.a: Universidad Nacional Autónoma de México

856.4.0.u: http://veterinariamexico.unam.mx/index.php/vet/article/view/787/796

100.1.#.a: Sumano, Héctor; Valencia, José A.; Viveros, Marcela; Tapia Pérez, Graciela; Gutiérrez, Lilia

524.#.#.a: Sumano, Héctor, et al. (2020). Efficacy of an extended-release tilmicosin preparation and tulathromycin in the treatment of bovine respiratory disease. Veterinaria México OA; Vol. 7 Núm. 4, 2020. Recuperado de https://repositorio.unam.mx/contenidos/4119816

245.1.0.a: Efficacy of an extended-release tilmicosin preparation and tulathromycin in the treatment of bovine respiratory disease

502.#.#.c: Universidad Nacional Autónoma de México

561.1.#.a: Facultad de Medicina Veterinaria y Zootecnia, UNAM

264.#.0.c: 2020

264.#.1.c: 2020-12-16

506.1.#.a: La titularidad de los derechos patrimoniales de esta obra pertenece a las instituciones editoras. Su uso se rige por una licencia Creative Commons BY 4.0 Internacional, https://creativecommons.org/licenses/by/4.0/legalcode.es, fecha de asignación de la licencia 2020-12-16, para un uso diferente consultar al responsable jurídico del repositorio por medio del correo electrónico vetmexicooa@gmail.com

884.#.#.k: http://veterinariamexico.unam.mx/index.php/vet/article/view/787

001.#.#.#: oai:ojs.pkp.sfu.ca:article/787

041.#.7.h: eng

520.3.#.a: A trial to evaluate the treatment of bovine respiratory disease (brd) was established with tulathromycin (tul-group) and tilmicosin (til-group). This latter antibacterial drug is pharmaceutically prepared for 8-10 d sustained release. The challenge was carried out with spontaneously brd-affected bulls, divided into til-group (ɳ=44) and tul-group (ɳ=50). bulls were treated only once with either antibacterial drugs. bacteriological analysis, arterial and venous blood chemistry, gasometrical parameters, and body temperature were obtained before and after treatment. The clinical cure rate was registered on days 7, 15, and 30. no mortality was observed. clinical cure was statistically undistinguishable on these days (p> 0.05), and in both groups, all animals were considered healthy until day 30. only customary pathogens were isolated i.e., mannhemia hemolytica 38.88% (70/180), pasteurella multocida 26.11% (47/180), histophilus somni 18.33% (33/180, and trueperella pyogenes 16.66% (30/180).

773.1.#.t: Veterinaria México OA; Vol. 7 Núm. 4 (2020)

773.1.#.o: http://veterinariamexico.unam.mx/index.php/vet/index

046.#.#.j: 2021-10-20 00:00:00.000000

022.#.#.a: ISSN electrónico: 2448-6760

310.#.#.a: Trimestral

264.#.1.b: Facultad de Medicina Veterinaria y Zootecnia, UNAM

758.#.#.1: http://veterinariamexico.unam.mx/index.php/vet/index

doi: https://doi.org/10.22201/fmvz.24486760e.2020.4.787

856.#.0.q: application/pdf

file_creation_date: 2020-12-17 21:23:28.0

file_modification_date: 2020-12-18 19:02:15.0

file_name: a466563d54638a56d9fe8b3a90a35e57b38df14423c290c1efe71131de0d7130.pdf

file_pages_number: 15

file_format_version: application/pdf; version=1.4

file_size: 1054988

last_modified: 2021-11-09 13:10:00

license_url: https://creativecommons.org/licenses/by/4.0/legalcode.es

license_type: by

No entro en nada

No entro en nada 2

Artículo

Efficacy of an extended-release tilmicosin preparation and tulathromycin in the treatment of bovine respiratory disease

Sumano, Héctor; Valencia, José A.; Viveros, Marcela; Tapia Pérez, Graciela; Gutiérrez, Lilia

Facultad de Medicina Veterinaria y Zootecnia, UNAM, publicado en Veterinaria México OA, y cosechado de Revistas UNAM

Licencia de uso

Procedencia del contenido

Entidad o dependencia
Facultad de Medicina Veterinaria y Zootecnia, UNAM
Revista
Repositorio
Contacto
Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx

Cita

Sumano, Héctor, et al. (2020). Efficacy of an extended-release tilmicosin preparation and tulathromycin in the treatment of bovine respiratory disease. Veterinaria México OA; Vol. 7 Núm. 4, 2020. Recuperado de https://repositorio.unam.mx/contenidos/4119816

Descripción del recurso

Autor(es)
Sumano, Héctor; Valencia, José A.; Viveros, Marcela; Tapia Pérez, Graciela; Gutiérrez, Lilia
Tipo
Artículo de Investigación
Área del conocimiento
Biotecnología y Ciencias Agropecuarias
Título
Efficacy of an extended-release tilmicosin preparation and tulathromycin in the treatment of bovine respiratory disease
Fecha
2020-12-16
Resumen
A trial to evaluate the treatment of bovine respiratory disease (brd) was established with tulathromycin (tul-group) and tilmicosin (til-group). This latter antibacterial drug is pharmaceutically prepared for 8-10 d sustained release. The challenge was carried out with spontaneously brd-affected bulls, divided into til-group (ɳ=44) and tul-group (ɳ=50). bulls were treated only once with either antibacterial drugs. bacteriological analysis, arterial and venous blood chemistry, gasometrical parameters, and body temperature were obtained before and after treatment. The clinical cure rate was registered on days 7, 15, and 30. no mortality was observed. clinical cure was statistically undistinguishable on these days (p> 0.05), and in both groups, all animals were considered healthy until day 30. only customary pathogens were isolated i.e., mannhemia hemolytica 38.88% (70/180), pasteurella multocida 26.11% (47/180), histophilus somni 18.33% (33/180, and trueperella pyogenes 16.66% (30/180).
Idioma
eng
ISSN
ISSN electrónico: 2448-6760

Enlaces